MOSCOW: According to a report published in Russian government mouthpiece Sputnik, some Indian companies have sought to know technical details of the Phase 1 and Phase 2 clinical trials of Russia’s Sputnik V vaccine that has become world’s first registered vaccine for COVID-19.
In a report, the Russian government mouthpiece has said, “Indian companies have asked the Russian Direct Investment Fund (RDIF) to provide the technical details of the Phase 1 and Phase 2 clinical trials of Russia’s Sputnik V vaccine.”
“Indian companies have also asked for production of vaccines in India for third country exports and production of vaccines for use in India after regulatory clearances,” the report quoted sources at the Indian embassy in Russia.
In another report, Sputnik said that the Indian ambassador to Russia, Venkatesh Varma, has said discussions with the head of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, on the topic of bilateral cooperation on a potential vaccine against Covid-19 were productive.
Russian President Vladimir Putin on Tuesday announced that Russia has developed the world’s first vaccine against Covid-19 that works “quite effectively” and forms a “stable immunity” against the deadly disease as he disclosed that one of his daughters has already been vaccinated.
